Call Options

21 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $917,504 - $1.12 Million
5,600 Added 2.78%
207,400 $41 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $15.6 Million - $18.2 Million
100,900 Added 100.0%
201,800 $34.6 Million
Q1 2024

May 09, 2024

BUY
$159.82 - $182.1 $16.1 Million - $18.4 Million
100,900 New
100,900 $18.4 Million
Q2 2022

Aug 11, 2022

SELL
$137.62 - $174.96 $34.6 Million - $44 Million
-251,700 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$131.98 - $163.75 $12.3 Million - $15.2 Million
93,100 Added 58.7%
251,700 $40.8 Million
Q4 2021

Feb 10, 2022

SELL
$107.43 - $135.93 $26.2 Million - $33.2 Million
-243,900 Reduced 60.6%
158,600 $21.5 Million
Q3 2021

Nov 12, 2021

SELL
$106.4 - $120.78 $9.87 Million - $11.2 Million
-92,800 Reduced 18.74%
402,500 $43.4 Million
Q2 2021

Aug 12, 2021

BUY
$105.21 - $117.21 $46.8 Million - $52.2 Million
445,200 Added 888.62%
495,300 $55.8 Million
Q1 2021

May 17, 2021

BUY
$102.3 - $112.62 $5.13 Million - $5.64 Million
50,100 New
50,100 $5.42 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $17.5 Million - $20.5 Million
-203,400 Closed
0 $0
Q2 2020

Aug 12, 2020

BUY
$73.37 - $98.18 $8.03 Million - $10.8 Million
109,500 Added 116.61%
203,400 $20 Million
Q1 2020

May 13, 2020

SELL
$64.5 - $97.79 $29.7 Million - $45.1 Million
-460,700 Reduced 83.07%
93,900 $7.15 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $7.36 Million - $9.21 Million
102,100 Added 22.56%
554,600 $49.1 Million
Q3 2019

Nov 12, 2019

BUY
$62.98 - $75.72 $12.1 Million - $14.5 Million
191,400 Added 73.31%
452,500 $34.3 Million
Q2 2019

Aug 12, 2019

SELL
$65.7 - $83.98 $35.2 Million - $45 Million
-535,600 Reduced 67.23%
261,100 $19 Million
Q1 2019

May 10, 2019

BUY
$77.14 - $90.79 $38.7 Million - $45.6 Million
501,800 Added 170.16%
796,700 $64.2 Million
Q4 2018

Feb 13, 2019

BUY
$77.85 - $96.01 $3.92 Million - $4.84 Million
50,400 Added 20.61%
294,900 $27.2 Million
Q3 2018

Nov 09, 2018

SELL
$88.91 - $98.84 $8.11 Million - $9.01 Million
-91,200 Reduced 27.17%
244,500 $23.1 Million
Q2 2018

Aug 08, 2018

BUY
$89.78 - $106.23 $18.8 Million - $22.3 Million
209,500 Added 166.01%
335,700 $31.1 Million
Q1 2018

May 09, 2018

BUY
$92.01 - $123.21 $8.05 Million - $10.8 Million
87,500 Added 226.1%
126,200 $11.9 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $2.7 Million - $3.45 Million
38,700
38,700 $3.44 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.